A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo.

International journal of oncology

Volumn 22, Issue 1, 2003, Pages 93-98

  Holle, Lori ^a   Song, Wendy ^a   Holle, Eric ^a   Wei, Yanzhang ^a   Wagner, Thomas ^a   Yu, Xianzhong ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; AVIDIN; GELATINASE A; LACTATE DEHYDROGENASE; MELITTIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; C57BL MOUSE; CELL LINE; EXPERIMENTAL MELANOMA; METABOLISM; MOLECULAR GENETICS; MOUSE; PATHOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; AVIDIN; CELL LINE; L-LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE 2; MELANOMA, EXPERIMENTAL; MELITTEN; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA;

EID: 0347475762     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.22.1.93     Document Type: Article

References (0)